HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology1530 papers

Moyamoya disease

Last edited: 27 days ago

Overview

Moyamoya disease is a chronic, progressive cerebrovascular disorder characterized by stenosis or occlusion of the internal carotid arteries, leading to the development of compensatory collateral vessels resembling a "puff of smoke" on angiography 1 44.

Diagnosis

Key Diagnostic Criteria: Narrowing of the internal carotid arteries, characteristic "puff of smoke" collateral vessels on cerebral angiography 1 44.

Recommended Tests:

- Cerebral angiography (gold standard) 1. - Magnetic resonance vessel wall imaging (MR VWI) for detailed vessel wall assessment 3 11 38. - Contrast-enhanced MR vessel wall imaging to evaluate enhanced sulci 3. - Indocyanine green videoangiography for intraoperative hemodynamic assessment 2 12.

Grading: Modified Suzuki classification for angiographic severity 1.

Management

First-Line Treatments:

- Revascularization surgery (e.g., STA-MCA bypass) 7 21 40. - Direct vs. indirect bypass with considerations for hemodynamic outcomes 5.

Adjunctive Treatments:

- Antiplatelet therapy (e.g., aspirin) post-bypass to prevent thrombosis 52. - Strict blood pressure control, especially in pediatric patients to reduce stroke risk 8. - Management of cerebral hyperperfusion syndrome with careful intraoperative monitoring and postoperative BP control 2 18.

Special Populations

Pediatrics:

- Close monitoring for hemorrhagic events and strict BP control postoperatively 8 17.

Pregnancy:

- Limited evidence; mode of birth should be individualized based on maternal and fetal risks 20.

Comorbidities:

- Consideration of hereditary spherocytosis association and tailored management 14.

Key Recommendations

Perform cerebral angiography for definitive diagnosis of Moyamoya disease (Evidence: Strong 1 44).

Utilize revascularization surgery (e.g., STA-MCA bypass) as the primary treatment approach (Evidence: Strong 7 40).

Maintain strict blood pressure control postoperatively, particularly in pediatric patients, to mitigate stroke risk (Evidence: Moderate 8).

Implement antiplatelet therapy post-bypass surgery to reduce the risk of thrombosis (Evidence: Moderate 52).

Intraoperative and postoperative monitoring for cerebral hyperperfusion syndrome is crucial to prevent complications (Evidence: Moderate 2 18).

References

Showing 100 most recent of 782 indexed papers.

1 Manjunath N, Honavalli Murali S, Nair P, Kesavadas C, Patnaik BSV, Sudhir BJ. Quantifying the morphological variations of internal carotid artery in moyamoya angiopathy. British journal of neurosurgery 2026. link 2 Zhang X, Ni W, Hu X, Yang H, Su J, Jiang H et al.. Unusual Synchronous Arbitrary-Gate Doppler Spectra Enable Intraoperative Hemodynamic Warning of Cerebral Hyperperfusion Syndrome on Moyamoya Disease. CNS neuroscience & therapeutics 2026. link 3 Hirayama A, Sorimachi T, Hashimoto J, Sunaga A, Shigematsu H, Osada T et al.. Correlation Between Contrast-Enhanced Magnetic Resonance Vessel Wall Imaging and Cerebral Hemodynamic Reserve in Moyamoya Disease. World neurosurgery 2026. link 4 Li B, Liu Y, Du X, Liu S, Wang X, Wang S et al.. Champagne bottle neck sign predicts intracranial hemorrhage in Moyamoya disease: A long-term follow-up study. Clinical neurology and neurosurgery 2026. link 5 Sarikonda A, Quraishi D, Momin A, Lan M, Kabani AS, Adegbite S et al.. High flow, at a higher cost? A pilot study comparing direct vs. indirect bypass for Moyamoya disease using time-driven activity-based costing. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2026. link 6 Kim RY, Lee CJ, Baek SO. Scalp Reconstruction With Free Tissue Transfer Using Descending Branch of Lateral Circumflex Femoral Vessels as Interposition Graft. The Journal of craniofacial surgery 2026. link 7 Ogasawara K, Kobayashi M, Fujiwara S, Chida K, Koji T, Akamatsu Y. Impact of revascularization strategy on postoperative cognitive function and return-to-work in adults with ischemic moyamoya disease. Neurological research 2026. link 8 Pal R, Cheronis C, Mayne E, Steinberg GK, Lee S. Blood Pressure Management and Postoperative Stroke Risk in Pediatric Moyamoya Disease. Pediatric neurology 2026. link 9 Wijaya JH, Consuegra MQ, Perez-Chadid DA, Azmi A, Madrigal JPA, Shahrestani S et al.. The role of artificial intelligence in estimating stroke events in Moyamoya patients: A systematic review and meta-analysis of diagnostic test accuracy. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2026. link 10 Otomo M, Tashiro R, Tokuno H, Kanoke A, Tominaga K, Nagai A et al.. Decreased <italic>Lactococcus lactis</italic> and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation. Cerebrovascular diseases (Basel, Switzerland) 2026. link 11 Wang B, Li X, Song X, Li C, Nie S, Zhang M. Value of MR high-resolution vessel wall imaging in the Moyamoya-like collateral vessels diseases at the base of the brain. Medicine 2026. link 12 Ito M, Uchino H, Fujimura M. Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease: Impact of Prolonged Observations of Indocyanine Green Videoangiography. Cerebrovascular diseases (Basel, Switzerland) 2026. link 13 Ruppert-Gomez MR, Choi JH, Staffa SJ, Holste K, Xu J, Stratton C et al.. Patient perspective on large-language model responses to questions about Moyamoya. Acta neurochirurgica 2026. link 14 Yan L, Lu X, Yang B, Ma Y. Moyamoya syndrome associated with hereditary spherocytosis: pathogenesis, management, and an illustrative case with rapid radiological progression. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2026. link 15 Xu D, Ren R, Hu J, Wang L, Jiang B, Zhang M et al.. Unraveling the links between intracranial artery stenosis, cerebral perfusion, and white matter hyperintensity in moyamoya disease. European radiology 2026. link 16 Ying P, Wu H, Ren H, Li L. Application of Artificial Intelligence in the Diagnosis and Treatment of Moyamoya Disease: Current Status, Challenges, and Future Prospects. The neurologist 2026. link 17 Guo Q, Xie M, Wang J, Zhao C, Wang Z, Zhang R et al.. Pediatric Hemorrhagic Moyamoya Disease: Clinical Course, Treatment, and Outcomes. Neurology 2026. link 18 Choi S, Park JY, Jo WY, Shin KW, Park HP, Lee SH et al.. Effects of Scalp Nerve Block on Symptomatic Cerebral Hyperperfusion Syndrome After Combined Revascularization Surgery for Moyamoya Disease. Journal of neurosurgical anesthesiology 2026. link 19 Qi S, Long T, Zhao L, Zeng E, Mao C, Ling C et al.. Multiple arachnoid membrane opening to promote angiogenesis in adult patients with moyamoya disease after combined bypass surgery: a multicenter randomized controlled clinical trial. Journal of neurosurgery 2026. link 20 Kim JH, Song KH, Park MY, Lee SH, Lee JW, Kim HY et al.. Mode of Birth and Stroke Risk After Childbirth Among Women With Moyamoya Disease. JAMA network open 2026. link 21 Palmisciano P, Vernile B, Vadivelu S, Zuccarello M. Superficial Temporal Artery to Middle Cerebral Artery (STA-MCA) bypass: How I do it. Acta neurochirurgica 2026. link 22 Ahmad M, Klaas JP, Lanzino G, Rinaldo L, McCarter SJ, Somers VK et al.. Characteristics of sleep disturbance in Moyamoya disease. Sleep medicine 2026. link 23 Devalckeneer A, Bordier C, Delaby G, Rogeau A, Henon H, Bretzner M et al.. Toward Semiautomated Analysis of Cerebrovascular Reserve: Enhancing Objective Comparisons Using 99m Tc-HMPAO SPECT With Acetazolamide in Moyamoya. Neurosurgery 2026. link 24 Das S, Dewasi S, Santra A, Pandit A, Dubey S. Transient ischemic attack after bee sting unmasking Moyamoya Angiopathy. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2026. link 25 Tashiro R, Fujimura M, Nishizawa T, Tominaga K, Kanoke A, Endo H. Diagnostic Values of the "To and Fro" Conflict Sign on Intraoperative Indocyanine Green Video Angiography as a Warning Sign of the Focal Cerebral Hyperperfusion and Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Bypass for Adult Patients with Moyamoya Disease. Cerebrovascular diseases (Basel, Switzerland) 2026. link 26 Yu J, Li X, Liu W. Bioinformatic analysis and experimental validation of mitochondria-related genes as novel biomarkers for moyamoya disease. Computational biology and chemistry 2026. link 27 Li H, Zhang S, Li Y, An X, Song Y, Yang X et al.. Neurosurgical Robot-Assisted Navigation Enhances Precision in Bypass Surgery for Moyamoya Disease: A Study of Vascular Protection and Haemodynamic Optimization. The international journal of medical robotics + computer assisted surgery : MRCAS 2026. link 28 Patel R, Memon M, Mendoza JA, Qadeer YK, Tangsrivimol JA, Krittanawong C. Precision medicine in Moyamoya vasculopathy. Current opinion in neurology 2026. link 29 Xiao J, Wei L, Chen D, Qiu X, Yan J, Li Y et al.. Spatial transcriptomics reveals TGF-β-driven endothelial-mesenchymal transition in vascular remodeling of moyamoya disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2026. link 30 Feng Z, Chang Y, Jin X, Yu W, Fu C. Clinical features and endovascular treatment of ruptured peripheral cerebral aneurysms associated with moyamoya disease: an 8-year single-center experience. Annals of medicine 2025. link 31 Ma S, Chen Z, Huang B, Wang M. Drug-Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 32 Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T et al.. Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study. Journal of neurosurgery 2025. link 33 Ling H, Huang H, Fu B, Pan X, Gao L, Yan W. Clinical Characteristics and Multi-Model Imaging Analysis of Moyamoya Disease: An Observational Study. The Journal of craniofacial surgery 2025. link 34 Sasagasako T, Mineharu Y, Funaki T, Fushimi Y, Chihara H, Park S et al.. RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease. Translational stroke research 2025. link 35 Torazawa S, Miyawaki S, Imai H, Hongo H, Ono H, Ogawa S et al.. Association of Genetic Variants with Postoperative Donor Artery Development in Moyamoya Disease: RNF213 and Other Moyamoya Angiopathy-Related Gene Analysis. Translational stroke research 2025. link 36 Yoshioka H, Wakai T, Hashimoto K, Tateoka T, Fukuda N, Horiuchi R et al.. Iodine-123-Iomazenil Single-Photon Emission Computed Tomography Revealed Recovery of Neuronal Viability in Association With Improvement of Cognitive Dysfunction After Revascularization in Moyamoya Disease. Neurosurgery 2025. link 37 Zhu H, Zhu C, Liu T, Wang P, Li W, Zhang Q et al.. Alterations in the Glymphatic System and Association with Brain Structure and Cognitive Function in Moyamoya Disease. Translational stroke research 2025. link 38 Shahabi M, Zareshahi N, Kiani I, Gouravani M, Beikmarzehei A, Farahmand Y et al.. High-resolution vessel wall MRI in Moyamoya disease: a systematic review and meta-analysis of diagnostic and prognostic applications. Neuroradiology 2025. link 39 Kim NY, Shin KW, Jo WY, Oh H, Lee SH, Cho WS et al.. A High Immediate Postoperative Systemic Immune-inflammation Index Is Associated With Postoperative Symptomatic Cerebral Infarction in Moyamoya Patients Undergoing Combined Revascularization Surgery. Journal of neurosurgical anesthesiology 2025. link 40 Luo Y, Guo C, Wu S, Sun X. Treatment Options for Patients With Moyamoya Disease: A Retrospective Cohort Study. Revista de neurologia 2025. link 41 Jiang P, Liu Z, Chen H, Shen C, Zhang J, Hao X et al.. Choroid plexus enlargement correlates with cognitive dysfunction and disease progression in Moyamoya disease. Neurosurgical review 2025. link 42 Rifino N, Hervè D, Acerbi F, Kuroda S, Lanzino G, Vajkoczy P et al.. Diagnosis and management of adult Moyamoya angiopathy: An overview of guideline recommendations and identification of future research directions. International journal of stroke : official journal of the International Stroke Society 2025. link 43 Wadhwa A, Han K, Ramirez-Velandia F, Alwakaa O, Riordan C, McNeil E et al.. Stroke-Related Outcomes in Moyamoya Disease Compared with Moyamoya Syndromes: A Propensity-Matched Analysis. World neurosurgery 2025. link 44 Weng R, Ren S, Su J, Jiang H, Yang H, Gao X et al.. The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a . European journal of nuclear medicine and molecular imaging 2025. [link 45 Ayub Jajja S, Kunwar D, Ahmed S, Akbar A, Anjum AS, Anjum S. Moyamoya disease in an adolescent with subarachnoid hemorrhage: a case report. The International journal of neuroscience 2025. link 46 Muljadi R, Koesbandono, Pratama TA, Octavius GS. Moyamoya disease and moyamoya syndrome: A case series from multicentre private hospitals in Indonesia. Neurocirugia 2025. link 47 Wen Y, Chen J, Long T, Chen F, Wang Z, Chen S et al.. miR-6760-5p suppresses neoangiogenesis by targeting Yes-associated protein 1 in patients with moyamoya disease undergoing indirect revascularization. Gene 2025. link 48 Wang H, Li J, Chen J, Li M, Liu J, Wei L et al.. Multi-parameter MRI-Based Machine Learning Model to Evaluate the Efficacy of STA-MCA Bypass Surgery for Moyamoya Disease: A Pilot Study. Journal of imaging informatics in medicine 2025. link 49 Weng R, Xu Y, Gao X, Cao L, Su J, Yang H et al.. Non-Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025. link 50 Kim RY, Lee CJ, Baek SO. Complex Scalp Reconstruction in Moyamoya Disease Using Distant Flap After Free Tissue Transfer Failure. The Journal of craniofacial surgery 2025. link 51 Li J, He Q, Zheng Z, Liu C, Zhang B, Mou S et al.. Comprehensive Analysis and In Vitro Verification of Endothelial-Mesenchymal Transition-Related Genes in Moyamoya Disease. Molecular neurobiology 2025. link 52 Si J, Kang X, Li Z, Hao J, Zhang L. Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: A meta-analysis. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2025. link 53 Zeng C, Zhai Y, Ge P, Liu C, Yu X, Liu W et al.. Glymphatic Impairment Associated with Neurocognitive Dysfunction in Moyamoya Disease. Translational stroke research 2025. link 54 Mertens R, Siebert E, Endres M, Nikolaus M, Danyel M, Vajkoczy P. Moyamoya Disease: Pathophysiology, Diagnosis, and Treatment. Deutsches Arzteblatt international 2025. link 55 Kim MS, Nam S, Lee SU, Park SJ, Woo SJ, Lee J et al.. Moyamoya Disease Increased the Risk of Retinal Vascular Occlusion: A Nationwide Cohort Study in Korea. Ophthalmology. Retina 2025. link 56 Weber DS, Huang KT, See AP. Fractal analysis of healthy and diseased vasculature in pediatric Moyamoya disease. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2025. link 57 Kuang G, Ji H, Zheng J, Li X, Luo K, Hu Y et al.. Association between angiographic and clinical outcomes after STA-MCA bypass in adult moyamoya disease. European stroke journal 2025. link 58 Liu C, Mou S, Zhang B, Pang Y, Chan L, Li J et al.. Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients with Moyamoya Disease. Inflammation 2025. link 59 Tokairin K, Ito M, Lee AG, Teo M, He S, Cheng MY et al.. Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease. Translational stroke research 2025. link 60 Venema M, Albuainain F, Schot R, Roozenbeek B, Sleutels F, van Ham T et al.. BRCC3 -Associated Syndromic Moyamoya Angiopathy Diagnosed Through Clinical RNA Sequencing. Clinical genetics 2025. link 61 Raju A. Association between trisomy 21 and 'puff of smoke' with an unusual presentation of transient ischaemic attack. BMJ case reports 2025. link 62 Ran KR, Nair SK, Srinivas T, Xie ME, Kilgore CB, Ye X et al.. Hemoglobin Drop is Associated with Early Post-operative Stroke Following Revascularization Surgery for Moyamoya Disease. Journal of neurosurgical anesthesiology 2025. link 63 Suzuki T, Hasegawa H, Fujiwara H, Shibuya K, Okamoto K, Oishi M. Visualization of cortical neoangiogenesis after combined revascularization surgery in moyamoya disease using silent MRA. Neuroradiology 2025. link 64 Grosset L, Stepanian A, Labeyrie MA, Civelli V, Chabriat H, Siguret V et al.. Moyamoya Angiopathy and Antiphospholipid Antibodies: A Coincidental Association?. Stroke 2025. link 65 Ahmad SA, Gatti JR, Peterson RK, Burton N, Malone LA, Sun LR. Patient-Reported Outcomes in Childhood Moyamoya Arteriopathy. Pediatric neurology 2025. link 66 Yang F, Li X, Wang X, Chen X, Niu Y, Zhang Y et al.. Analysis of Optic Disc Morphology and the Peripapillary Retinal and Choroidal Thickness by the Swept Source Optical Coherence Tomography in Patients with Moyamoya Disease. Ophthalmic research 2025. link 67 Musmar B, Roy JM, Abdalrazeq H, Kaul A, Atallah E, El Naamani K et al.. Comparative Outcomes of Unilateral vs Bilateral Revascularization in Moyamoya Disease: A Multicenter Retrospective Study. Neurosurgery 2025. link 68 Yamamoto S, Akai T, Kashiwazaki D, Maruyama K, Hori E, Akioka N et al.. Impact of Surgical Revascularization on Regression of Enlarged Perivascular Spaces in Adult Moyamoya Disease. Translational stroke research 2025. link 69 Mineharu Y, Kamata T, Tomoto M, Sato N, Tamada Y, Funaki T et al.. Peripheral blood . Stroke and vascular neurology 2025. link 70 Torazawa S, Miyawaki S, Imai H, Hongo H, Ishigami D, Shimizu M et al.. Association of rare variants in RNF213 with severe progression of intracranial artery stenosis in quasi-moyamoya disease. Journal of neurosurgery 2025. link 71 Pang CH, Lee SH, Choi TW, Byoun HS, Kim YD, Ban SP et al.. Prediction of contralateral progression in patients with bilateral nonhemorrhagic moyamoya disease following unilateral revascularization surgery. Journal of neurosurgery 2025. link 72 Liu K, He L. Post-anesthesia care unit delirium in children with moyamoya disease undergoing indirect revascularization: incidence and risk factors. Korean journal of anesthesiology 2025. link 73 Szarek D, Ito M, Uchino H, Lubkowska K, Tokairin K, Fujimura M. Distinct impact of RNF213 p.R4810K genotype on transdural collateral formation across Japanese Asian and Polish Caucasian Moyamoya patients. Neurosurgical review 2025. link 74 Ran Y, Fan Y, Wu S, Chen C, Li Y, Gao T et al.. TdCCA with Dual-Modal Signal Fusion: Degenerated Occipital and Frontal Connectivity of Adult Moyamoya Disease for Early Identification. Translational stroke research 2025. link 75 Yamada H, Funaki T, Fushimi Y, Yamao Y, Hidaka Y, Kikuchi T et al.. Early radiological reduction of periventricular anastomosis after direct bypass surgery for adult moyamoya disease. Journal of neurosurgery 2025. link 76 Wang L, Han D, Liao M, Zha J, Li L, Fan H et al.. Identification of the optimal thresholds for the hypoperfusion intensity ratio in moyamoya disease. Journal of neurosurgery 2025. link 77 Guo Q, Fan YN, Wang QN, Li J, Han C, Zou Z et al.. Nomogram for Predicting Long-term Outcomes of Encephaloduroarteriosynangiosis in Toddlers with Moyamoya Disease: a Longitudinal and Cross-sectional Study. Translational stroke research 2025. link 78 Seshan JR, Kapoor I, Prabhakar H, Mahajan C. Effect of propofol versus sevoflurane on cerebral oxygenation in childhood Moyamoya disease. A near infrared spectroscopy study. Revista espanola de anestesiologia y reanimacion 2025. link 79 Rios-Zermeno J, Ghaith AK, El Hajj VG, Soltan F, Greco E, Michaelides L et al.. Extracranial-Intracranial Bypass for Moyamoya Disease: The Influence of Racial and Socioeconomic Disparities on Outcomes - A National Inpatient Sample Analysis. World neurosurgery 2024. link 80 Li X, Liu G, Ni Y, Song D, Yang F, Wang X et al.. Analysis of macula structural changes in Moyamoya disease using AI-assisted OCT. Photodiagnosis and photodynamic therapy 2024. link 81 Mamiya T, Araki Y, Taoka T, Fujita N, Yokoyama K, Uda K et al.. Characteristics of donor vessels and cerebral blood flow in the chronic phase after combined revascularization surgery for moyamoya disease. Clinical neurology and neurosurgery 2024. link 82 Lu M, Liu S, Peng P, Liu D, Liu Y, Sheng F et al.. The Characteristics of Extracranial Internal Carotid Artery and Their Relationship With Surgical Outcomes in Patients With Moyamoya Disease: A Combined Head-and-Neck Vessel Wall MR Imaging Study. Journal of magnetic resonance imaging : JMRI 2024. link 83 Sun LR, Jordan LC, Smith ER, Aldana PR, Kirschen MP, Guilliams K et al.. Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study. Neurocritical care 2024. link 84 Zhang Q, Yin Z, Zhu C, Li W, Zhu H, Wang P et al.. Effectiveness of indirect revascularization for adult hemorrhagic moyamoya disease: a 10-year follow-up study. Journal of neurosurgery 2024. link 85 Li W, Zhao M, Liu X, Wang P, Zhu H, Zhang Q et al.. A novel system for evaluating collateralization of the external carotid artery after cerebral revascularization in moyamoya disease. Journal of neurosurgery 2024. link 86 Sato D, Miyawaki S, Imai H, Hongo H, Kiyofuji S, Koizumi S et al.. Clinical Characteristics of Immediate Contralateral Ischemia Subsequent to Revascularization for Moyamoya Disease. World neurosurgery 2024. link 87 Sun LR, Gatti JR, Ahmad SA, Burton N, Ziai W, Gottesman RF et al.. Transcranial Doppler in Childhood Moyamoya: An Underutilized Tool?. Pediatric neurology 2024. link 88 Huang C, Huang C, Zhan X. Predictive Factors for Seizures after Revascularization in Patients with Moyamoya Disease. World neurosurgery 2024. link 89 Li H, Cao X, Gu X, Dong M, Huang L, Mao C et al.. GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease. Neuroscience bulletin 2024. link 90 Zhang H, Lu M, Liu S, Liu D, Liu X, Shen X et al.. Predictors of Stroke Outcomes in Conservatively Treated Patients With Moyamoya Disease: A Follow-up MRI Study. Journal of magnetic resonance imaging : JMRI 2024. link 91 Birkeland P, Hansen V, Tharmabalan V, Lauritsen J, Nielsen T, Truelsen T et al.. Long-term stroke risk in Moyamoya disease. International journal of stroke : official journal of the International Stroke Society 2024. link 92 Abhinav K, Lee AG, Pendharkar AV, Bigder M, Bet A, Rosenberg-Hasson Y et al.. Comprehensive Profiling of Secreted Factors in the Cerebrospinal Fluid of Moyamoya Disease Patients. Translational stroke research 2024. link 93 Xu D, Yu X, Hu J, Yu Y, Wang L, Jiang B et al.. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease. European radiology 2024. link 94 Torazawa S, Miyawaki S, Imai H, Hongo H, Ishigami D, Shimizu M et al.. RNF213 p.Arg4810Lys Wild Type is Associated with De Novo Hemorrhage in Asymptomatic Hemispheres with Moyamoya Disease. Translational stroke research 2024. link 95 Teo CKA, Zheng Y, Lin JB, Teoh HL, Chan BPL, Sharma VK et al.. Outcomes after surgical revascularization for adult Moyamoya disease: A Southeast Asian tertiary centre experience. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024. link 96 Oh WO, Heo YJ, Han J, Lee E. Analyzing symptom experiences and pathways to enhancing quality of life in adolescents with Moyamoya disease. Journal of pediatric nursing 2024. link 97 Slingerland AL, Keusch DS, Lehman LL, Smith ER, Srivastava S, See AP. Yield of genetic evaluation in non-syndromic pediatric moyamoya patients. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2024. link 98 Ryu J, Lee KM, Woo HG, Park JI, Choi SK. Morphologic differences between ruptured and unruptured choroidal anastomosis in adult moyamoya disease: a high-resolution vessel wall imaging study. Journal of neurosurgery 2024. link 99 Thamamongood T, Hara S, Akagawa H, Inaji M, Tanaka Y, Nariai T et al.. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease. Neurologia medico-chirurgica 2024. link 100 Zhang H, Lu W, Liang J, Wang H, Zhao Y, Yang X et al.. Risk factors of rupture and mortality for intracranial aneurysms associated with moyamoya disease: a multicenter retrospective study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024. link

Original source

[1]
Quantifying the morphological variations of internal carotid artery in moyamoya angiopathy. — Manjunath N, Honavalli Murali S, Nair P, Kesavadas C, Patnaik BSV, Sudhir BJ British journal of neurosurgery (2026)
[2]
Unusual Synchronous Arbitrary-Gate Doppler Spectra Enable Intraoperative Hemodynamic Warning of Cerebral Hyperperfusion Syndrome on Moyamoya Disease. — Zhang X, Ni W, Hu X, Yang H, Su J, Jiang H et al. CNS neuroscience & therapeutics (2026)
[3]
Correlation Between Contrast-Enhanced Magnetic Resonance Vessel Wall Imaging and Cerebral Hemodynamic Reserve in Moyamoya Disease. — Hirayama A, Sorimachi T, Hashimoto J, Sunaga A, Shigematsu H, Osada T et al. World neurosurgery (2026)
[4]
Champagne bottle neck sign predicts intracranial hemorrhage in Moyamoya disease: A long-term follow-up study. — Li B, Liu Y, Du X, Liu S, Wang X, Wang S et al. Clinical neurology and neurosurgery (2026)
[5]
High flow, at a higher cost? A pilot study comparing direct vs. indirect bypass for Moyamoya disease using time-driven activity-based costing. — Sarikonda A, Quraishi D, Momin A, Lan M, Kabani AS, Adegbite S et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2026)
[6]
Scalp Reconstruction With Free Tissue Transfer Using Descending Branch of Lateral Circumflex Femoral Vessels as Interposition Graft. — Kim RY, Lee CJ, Baek SO The Journal of craniofacial surgery (2026)
[7]
Impact of revascularization strategy on postoperative cognitive function and return-to-work in adults with ischemic moyamoya disease. — Ogasawara K, Kobayashi M, Fujiwara S, Chida K, Koji T, Akamatsu Y Neurological research (2026)
[8]
Blood Pressure Management and Postoperative Stroke Risk in Pediatric Moyamoya Disease. — Pal R, Cheronis C, Mayne E, Steinberg GK, Lee S Pediatric neurology (2026)
[9]
The role of artificial intelligence in estimating stroke events in Moyamoya patients: A systematic review and meta-analysis of diagnostic test accuracy. — Wijaya JH, Consuegra MQ, Perez-Chadid DA, Azmi A, Madrigal JPA, Shahrestani S et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2026)
[10]
Decreased <italic>Lactococcus lactis</italic> and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation. — Otomo M, Tashiro R, Tokuno H, Kanoke A, Tominaga K, Nagai A et al. Cerebrovascular diseases (Basel, Switzerland) (2026)
[11]
Value of MR high-resolution vessel wall imaging in the Moyamoya-like collateral vessels diseases at the base of the brain. — Wang B, Li X, Song X, Li C, Nie S, Zhang M Medicine (2026)
[12]
Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease: Impact of Prolonged Observations of Indocyanine Green Videoangiography. — Ito M, Uchino H, Fujimura M Cerebrovascular diseases (Basel, Switzerland) (2026)
[13]
Patient perspective on large-language model responses to questions about Moyamoya. — Ruppert-Gomez MR, Choi JH, Staffa SJ, Holste K, Xu J, Stratton C et al. Acta neurochirurgica (2026)
[14]
Moyamoya syndrome associated with hereditary spherocytosis: pathogenesis, management, and an illustrative case with rapid radiological progression. — Yan L, Lu X, Yang B, Ma Y Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2026)
[15]
Unraveling the links between intracranial artery stenosis, cerebral perfusion, and white matter hyperintensity in moyamoya disease. — Xu D, Ren R, Hu J, Wang L, Jiang B, Zhang M et al. European radiology (2026)
[16]
Application of Artificial Intelligence in the Diagnosis and Treatment of Moyamoya Disease: Current Status, Challenges, and Future Prospects. — Ying P, Wu H, Ren H, Li L The neurologist (2026)
[17]
Pediatric Hemorrhagic Moyamoya Disease: Clinical Course, Treatment, and Outcomes. — Guo Q, Xie M, Wang J, Zhao C, Wang Z, Zhang R et al. Neurology (2026)
[18]
Effects of Scalp Nerve Block on Symptomatic Cerebral Hyperperfusion Syndrome After Combined Revascularization Surgery for Moyamoya Disease. — Choi S, Park JY, Jo WY, Shin KW, Park HP, Lee SH et al. Journal of neurosurgical anesthesiology (2026)
[19]
Multiple arachnoid membrane opening to promote angiogenesis in adult patients with moyamoya disease after combined bypass surgery: a multicenter randomized controlled clinical trial. — Qi S, Long T, Zhao L, Zeng E, Mao C, Ling C et al. Journal of neurosurgery (2026)
[20]
Mode of Birth and Stroke Risk After Childbirth Among Women With Moyamoya Disease. — Kim JH, Song KH, Park MY, Lee SH, Lee JW, Kim HY et al. JAMA network open (2026)
[21]
Superficial Temporal Artery to Middle Cerebral Artery (STA-MCA) bypass: How I do it. — Palmisciano P, Vernile B, Vadivelu S, Zuccarello M Acta neurochirurgica (2026)
[22]
Characteristics of sleep disturbance in Moyamoya disease. — Ahmad M, Klaas JP, Lanzino G, Rinaldo L, McCarter SJ, Somers VK et al. Sleep medicine (2026)
[23]
Toward Semiautomated Analysis of Cerebrovascular Reserve: Enhancing Objective Comparisons Using 99m Tc-HMPAO SPECT With Acetazolamide in Moyamoya. — Devalckeneer A, Bordier C, Delaby G, Rogeau A, Henon H, Bretzner M et al. Neurosurgery (2026)
[24]
Transient ischemic attack after bee sting unmasking Moyamoya Angiopathy. — Das S, Dewasi S, Santra A, Pandit A, Dubey S Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2026)
[25]
Diagnostic Values of the "To and Fro" Conflict Sign on Intraoperative Indocyanine Green Video Angiography as a Warning Sign of the Focal Cerebral Hyperperfusion and Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Bypass for Adult Patients with Moyamoya Disease. — Tashiro R, Fujimura M, Nishizawa T, Tominaga K, Kanoke A, Endo H Cerebrovascular diseases (Basel, Switzerland) (2026)
[26]
Bioinformatic analysis and experimental validation of mitochondria-related genes as novel biomarkers for moyamoya disease. — Yu J, Li X, Liu W Computational biology and chemistry (2026)
[27]
Neurosurgical Robot-Assisted Navigation Enhances Precision in Bypass Surgery for Moyamoya Disease: A Study of Vascular Protection and Haemodynamic Optimization. — Li H, Zhang S, Li Y, An X, Song Y, Yang X et al. The international journal of medical robotics + computer assisted surgery : MRCAS (2026)
[28]
Precision medicine in Moyamoya vasculopathy. — Patel R, Memon M, Mendoza JA, Qadeer YK, Tangsrivimol JA, Krittanawong C Current opinion in neurology (2026)
[29]
Spatial transcriptomics reveals TGF-β-driven endothelial-mesenchymal transition in vascular remodeling of moyamoya disease. — Xiao J, Wei L, Chen D, Qiu X, Yan J, Li Y et al. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2026)
[30]
Clinical features and endovascular treatment of ruptured peripheral cerebral aneurysms associated with moyamoya disease: an 8-year single-center experience. — Feng Z, Chang Y, Jin X, Yu W, Fu C Annals of medicine (2025)
[31]
Drug-Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging. — Ma S, Chen Z, Huang B, Wang M Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2025)
[32]
Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study. — Kuroda S, Yamamoto S, Funaki T, Fujimura M, Kataoka H, Hishikawa T et al. Journal of neurosurgery (2025)
[33]
Clinical Characteristics and Multi-Model Imaging Analysis of Moyamoya Disease: An Observational Study. — Ling H, Huang H, Fu B, Pan X, Gao L, Yan W The Journal of craniofacial surgery (2025)
[34]
RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease. — Sasagasako T, Mineharu Y, Funaki T, Fushimi Y, Chihara H, Park S et al. Translational stroke research (2025)
[35]
Association of Genetic Variants with Postoperative Donor Artery Development in Moyamoya Disease: RNF213 and Other Moyamoya Angiopathy-Related Gene Analysis. — Torazawa S, Miyawaki S, Imai H, Hongo H, Ono H, Ogawa S et al. Translational stroke research (2025)
[36]
Iodine-123-Iomazenil Single-Photon Emission Computed Tomography Revealed Recovery of Neuronal Viability in Association With Improvement of Cognitive Dysfunction After Revascularization in Moyamoya Disease. — Yoshioka H, Wakai T, Hashimoto K, Tateoka T, Fukuda N, Horiuchi R et al. Neurosurgery (2025)
[37]
Alterations in the Glymphatic System and Association with Brain Structure and Cognitive Function in Moyamoya Disease. — Zhu H, Zhu C, Liu T, Wang P, Li W, Zhang Q et al. Translational stroke research (2025)
[38]
High-resolution vessel wall MRI in Moyamoya disease: a systematic review and meta-analysis of diagnostic and prognostic applications. — Shahabi M, Zareshahi N, Kiani I, Gouravani M, Beikmarzehei A, Farahmand Y et al. Neuroradiology (2025)
[39]
A High Immediate Postoperative Systemic Immune-inflammation Index Is Associated With Postoperative Symptomatic Cerebral Infarction in Moyamoya Patients Undergoing Combined Revascularization Surgery. — Kim NY, Shin KW, Jo WY, Oh H, Lee SH, Cho WS et al. Journal of neurosurgical anesthesiology (2025)
[40]
Treatment Options for Patients With Moyamoya Disease: A Retrospective Cohort Study. — Luo Y, Guo C, Wu S, Sun X Revista de neurologia (2025)
[41]
Choroid plexus enlargement correlates with cognitive dysfunction and disease progression in Moyamoya disease. — Jiang P, Liu Z, Chen H, Shen C, Zhang J, Hao X et al. Neurosurgical review (2025)
[42]
Diagnosis and management of adult Moyamoya angiopathy: An overview of guideline recommendations and identification of future research directions. — Rifino N, Hervè D, Acerbi F, Kuroda S, Lanzino G, Vajkoczy P et al. International journal of stroke : official journal of the International Stroke Society (2025)
[43]
Stroke-Related Outcomes in Moyamoya Disease Compared with Moyamoya Syndromes: A Propensity-Matched Analysis. — Wadhwa A, Han K, Ramirez-Velandia F, Alwakaa O, Riordan C, McNeil E et al. World neurosurgery (2025)
[44]
The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [ — Weng R, Ren S, Su J, Jiang H, Yang H, Gao X et al. European journal of nuclear medicine and molecular imaging (2025)
[45]
Moyamoya disease in an adolescent with subarachnoid hemorrhage: a case report. — Ayub Jajja S, Kunwar D, Ahmed S, Akbar A, Anjum AS, Anjum S The International journal of neuroscience (2025)
[46]
Moyamoya disease and moyamoya syndrome: A case series from multicentre private hospitals in Indonesia. — Muljadi R, Koesbandono, Pratama TA, Octavius GS Neurocirugia (2025)
[47]
miR-6760-5p suppresses neoangiogenesis by targeting Yes-associated protein 1 in patients with moyamoya disease undergoing indirect revascularization. — Wen Y, Chen J, Long T, Chen F, Wang Z, Chen S et al. Gene (2025)
[48]
Multi-parameter MRI-Based Machine Learning Model to Evaluate the Efficacy of STA-MCA Bypass Surgery for Moyamoya Disease: A Pilot Study. — Wang H, Li J, Chen J, Li M, Liu J, Wei L et al. Journal of imaging informatics in medicine (2025)
[49]
Non-Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning. — Weng R, Xu Y, Gao X, Cao L, Su J, Yang H et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2025)
[50]
Complex Scalp Reconstruction in Moyamoya Disease Using Distant Flap After Free Tissue Transfer Failure. — Kim RY, Lee CJ, Baek SO The Journal of craniofacial surgery (2025)
[51]
Comprehensive Analysis and In Vitro Verification of Endothelial-Mesenchymal Transition-Related Genes in Moyamoya Disease. — Li J, He Q, Zheng Z, Liu C, Zhang B, Mou S et al. Molecular neurobiology (2025)
[52]
Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: A meta-analysis. — Si J, Kang X, Li Z, Hao J, Zhang L Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2025)
[53]
Glymphatic Impairment Associated with Neurocognitive Dysfunction in Moyamoya Disease. — Zeng C, Zhai Y, Ge P, Liu C, Yu X, Liu W et al. Translational stroke research (2025)
[54]
Moyamoya Disease: Pathophysiology, Diagnosis, and Treatment. — Mertens R, Siebert E, Endres M, Nikolaus M, Danyel M, Vajkoczy P Deutsches Arzteblatt international (2025)
[55]
Moyamoya Disease Increased the Risk of Retinal Vascular Occlusion: A Nationwide Cohort Study in Korea. — Kim MS, Nam S, Lee SU, Park SJ, Woo SJ, Lee J et al. Ophthalmology. Retina (2025)
[56]
Fractal analysis of healthy and diseased vasculature in pediatric Moyamoya disease. — Weber DS, Huang KT, See AP Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2025)
[57]
Association between angiographic and clinical outcomes after STA-MCA bypass in adult moyamoya disease. — Kuang G, Ji H, Zheng J, Li X, Luo K, Hu Y et al. European stroke journal (2025)
[58]
Innate Immune Cell Profiling in Peripheral Blood Mononuclear Cells of Patients with Moyamoya Disease. — Liu C, Mou S, Zhang B, Pang Y, Chan L, Li J et al. Inflammation (2025)
[59]
Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease. — Tokairin K, Ito M, Lee AG, Teo M, He S, Cheng MY et al. Translational stroke research (2025)
[60]
BRCC3 -Associated Syndromic Moyamoya Angiopathy Diagnosed Through Clinical RNA Sequencing. — Venema M, Albuainain F, Schot R, Roozenbeek B, Sleutels F, van Ham T et al. Clinical genetics (2025)
[61]
Association between trisomy 21 and 'puff of smoke' with an unusual presentation of transient ischaemic attack. — Raju A BMJ case reports (2025)
[62]
Hemoglobin Drop is Associated with Early Post-operative Stroke Following Revascularization Surgery for Moyamoya Disease. — Ran KR, Nair SK, Srinivas T, Xie ME, Kilgore CB, Ye X et al. Journal of neurosurgical anesthesiology (2025)
[63]
Visualization of cortical neoangiogenesis after combined revascularization surgery in moyamoya disease using silent MRA. — Suzuki T, Hasegawa H, Fujiwara H, Shibuya K, Okamoto K, Oishi M Neuroradiology (2025)
[64]
Moyamoya Angiopathy and Antiphospholipid Antibodies: A Coincidental Association? — Grosset L, Stepanian A, Labeyrie MA, Civelli V, Chabriat H, Siguret V et al. Stroke (2025)
[65]
Patient-Reported Outcomes in Childhood Moyamoya Arteriopathy. — Ahmad SA, Gatti JR, Peterson RK, Burton N, Malone LA, Sun LR Pediatric neurology (2025)
[66]
Analysis of Optic Disc Morphology and the Peripapillary Retinal and Choroidal Thickness by the Swept Source Optical Coherence Tomography in Patients with Moyamoya Disease. — Yang F, Li X, Wang X, Chen X, Niu Y, Zhang Y et al. Ophthalmic research (2025)
[67]
Comparative Outcomes of Unilateral vs Bilateral Revascularization in Moyamoya Disease: A Multicenter Retrospective Study. — Musmar B, Roy JM, Abdalrazeq H, Kaul A, Atallah E, El Naamani K et al. Neurosurgery (2025)
[68]
Impact of Surgical Revascularization on Regression of Enlarged Perivascular Spaces in Adult Moyamoya Disease. — Yamamoto S, Akai T, Kashiwazaki D, Maruyama K, Hori E, Akioka N et al. Translational stroke research (2025)
[69]
Peripheral blood — Mineharu Y, Kamata T, Tomoto M, Sato N, Tamada Y, Funaki T et al. Stroke and vascular neurology (2025)
[70]
Association of rare variants in RNF213 with severe progression of intracranial artery stenosis in quasi-moyamoya disease. — Torazawa S, Miyawaki S, Imai H, Hongo H, Ishigami D, Shimizu M et al. Journal of neurosurgery (2025)
[71]
Prediction of contralateral progression in patients with bilateral nonhemorrhagic moyamoya disease following unilateral revascularization surgery. — Pang CH, Lee SH, Choi TW, Byoun HS, Kim YD, Ban SP et al. Journal of neurosurgery (2025)
[72]
Post-anesthesia care unit delirium in children with moyamoya disease undergoing indirect revascularization: incidence and risk factors. — Liu K, He L Korean journal of anesthesiology (2025)
[73]
Distinct impact of RNF213 p.R4810K genotype on transdural collateral formation across Japanese Asian and Polish Caucasian Moyamoya patients. — Szarek D, Ito M, Uchino H, Lubkowska K, Tokairin K, Fujimura M Neurosurgical review (2025)
[74]
TdCCA with Dual-Modal Signal Fusion: Degenerated Occipital and Frontal Connectivity of Adult Moyamoya Disease for Early Identification. — Ran Y, Fan Y, Wu S, Chen C, Li Y, Gao T et al. Translational stroke research (2025)
[75]
Early radiological reduction of periventricular anastomosis after direct bypass surgery for adult moyamoya disease. — Yamada H, Funaki T, Fushimi Y, Yamao Y, Hidaka Y, Kikuchi T et al. Journal of neurosurgery (2025)
[76]
Identification of the optimal thresholds for the hypoperfusion intensity ratio in moyamoya disease. — Wang L, Han D, Liao M, Zha J, Li L, Fan H et al. Journal of neurosurgery (2025)
[77]
Nomogram for Predicting Long-term Outcomes of Encephaloduroarteriosynangiosis in Toddlers with Moyamoya Disease: a Longitudinal and Cross-sectional Study. — Guo Q, Fan YN, Wang QN, Li J, Han C, Zou Z et al. Translational stroke research (2025)
[78]
Effect of propofol versus sevoflurane on cerebral oxygenation in childhood Moyamoya disease. A near infrared spectroscopy study. — Seshan JR, Kapoor I, Prabhakar H, Mahajan C Revista espanola de anestesiologia y reanimacion (2025)
[79]
Extracranial-Intracranial Bypass for Moyamoya Disease: The Influence of Racial and Socioeconomic Disparities on Outcomes - A National Inpatient Sample Analysis. — Rios-Zermeno J, Ghaith AK, El Hajj VG, Soltan F, Greco E, Michaelides L et al. World neurosurgery (2024)
[80]
Analysis of macula structural changes in Moyamoya disease using AI-assisted OCT. — Li X, Liu G, Ni Y, Song D, Yang F, Wang X et al. Photodiagnosis and photodynamic therapy (2024)
[81]
Characteristics of donor vessels and cerebral blood flow in the chronic phase after combined revascularization surgery for moyamoya disease. — Mamiya T, Araki Y, Taoka T, Fujita N, Yokoyama K, Uda K et al. Clinical neurology and neurosurgery (2024)
[82]
The Characteristics of Extracranial Internal Carotid Artery and Their Relationship With Surgical Outcomes in Patients With Moyamoya Disease: A Combined Head-and-Neck Vessel Wall MR Imaging Study. — Lu M, Liu S, Peng P, Liu D, Liu Y, Sheng F et al. Journal of magnetic resonance imaging : JMRI (2024)
[83]
Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study. — Sun LR, Jordan LC, Smith ER, Aldana PR, Kirschen MP, Guilliams K et al. Neurocritical care (2024)
[84]
Effectiveness of indirect revascularization for adult hemorrhagic moyamoya disease: a 10-year follow-up study. — Zhang Q, Yin Z, Zhu C, Li W, Zhu H, Wang P et al. Journal of neurosurgery (2024)
[85]
A novel system for evaluating collateralization of the external carotid artery after cerebral revascularization in moyamoya disease. — Li W, Zhao M, Liu X, Wang P, Zhu H, Zhang Q et al. Journal of neurosurgery (2024)
[86]
Clinical Characteristics of Immediate Contralateral Ischemia Subsequent to Revascularization for Moyamoya Disease. — Sato D, Miyawaki S, Imai H, Hongo H, Kiyofuji S, Koizumi S et al. World neurosurgery (2024)
[87]
Transcranial Doppler in Childhood Moyamoya: An Underutilized Tool? — Sun LR, Gatti JR, Ahmad SA, Burton N, Ziai W, Gottesman RF et al. Pediatric neurology (2024)
[88]
Predictive Factors for Seizures after Revascularization in Patients with Moyamoya Disease. — Huang C, Huang C, Zhan X World neurosurgery (2024)
[89]
GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease. — Li H, Cao X, Gu X, Dong M, Huang L, Mao C et al. Neuroscience bulletin (2024)
[90]
Predictors of Stroke Outcomes in Conservatively Treated Patients With Moyamoya Disease: A Follow-up MRI Study. — Zhang H, Lu M, Liu S, Liu D, Liu X, Shen X et al. Journal of magnetic resonance imaging : JMRI (2024)
[91]
Long-term stroke risk in Moyamoya disease. — Birkeland P, Hansen V, Tharmabalan V, Lauritsen J, Nielsen T, Truelsen T et al. International journal of stroke : official journal of the International Stroke Society (2024)
[92]
Comprehensive Profiling of Secreted Factors in the Cerebrospinal Fluid of Moyamoya Disease Patients. — Abhinav K, Lee AG, Pendharkar AV, Bigder M, Bet A, Rosenberg-Hasson Y et al. Translational stroke research (2024)
[93]
White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease. — Xu D, Yu X, Hu J, Yu Y, Wang L, Jiang B et al. European radiology (2024)
[94]
RNF213 p.Arg4810Lys Wild Type is Associated with De Novo Hemorrhage in Asymptomatic Hemispheres with Moyamoya Disease. — Torazawa S, Miyawaki S, Imai H, Hongo H, Ishigami D, Shimizu M et al. Translational stroke research (2024)
[95]
Outcomes after surgical revascularization for adult Moyamoya disease: A Southeast Asian tertiary centre experience. — Teo CKA, Zheng Y, Lin JB, Teoh HL, Chan BPL, Sharma VK et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2024)
[96]
Analyzing symptom experiences and pathways to enhancing quality of life in adolescents with Moyamoya disease. — Oh WO, Heo YJ, Han J, Lee E Journal of pediatric nursing (2024)
[97]
Yield of genetic evaluation in non-syndromic pediatric moyamoya patients. — Slingerland AL, Keusch DS, Lehman LL, Smith ER, Srivastava S, See AP Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2024)
[98]
Morphologic differences between ruptured and unruptured choroidal anastomosis in adult moyamoya disease: a high-resolution vessel wall imaging study. — Ryu J, Lee KM, Woo HG, Park JI, Choi SK Journal of neurosurgery (2024)
[99]
Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease. — Thamamongood T, Hara S, Akagawa H, Inaji M, Tanaka Y, Nariai T et al. Neurologia medico-chirurgica (2024)
[100]
Risk factors of rupture and mortality for intracranial aneurysms associated with moyamoya disease: a multicenter retrospective study. — Zhang H, Lu W, Liang J, Wang H, Zhao Y, Yang X et al. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)

Share:Twitter Reddit LinkedIn